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Abstract
Introduction: The objective of this study was to evaluate the effects of two different mean arterial blood pressure
(MAP) targets on needs for resuscitation, organ dysfunction, mitochondrial respiration and inflammatory response
in a long-term model of fecal peritonitis.
Methods: Twenty-four anesthetized and mechanically ventilated pigs were randomly assigned (n = 8/group) to a
septic control group (septic-CG) without resuscitation until death or one of two groups with resuscitation
performed after 12 hours of untreated sepsis for 48 hours, targeting MAP 50-60 mmHg (low-MAP) or 75-85 mmHg
(high-MAP).
Results: MAP at the end of resuscitation was 56 ± 13 mmHg (mean ± SD) and 76 ± 17 mmHg respectively, for
low-MAP and high-MAP groups. One animal each in high- and low-MAP groups, and all animals in septic-CG died
(median survival time: 21.8 hours, inter-quartile range: 16.3-27.5 hours). Norepinephrine was administered to all animals of
the high-MAP group (0.38 (0.21-0.56) mcg/kg/min), and to three animals of the low-MAP group (0.00 (0.00-0.25) mcg/kg/
min; P = 0.009). The high-MAP group had a more positive fluid balance (3.3 ± 1.0 mL/kg/h vs. 2.3 ± 0.7 mL/kg/h; P =
0.001). Inflammatory markers, skeletal muscle ATP content and hemodynamics other than MAP did not differ between
low- and high-MAP groups. The incidence of acute kidney injury (AKI) after 12 hours of untreated sepsis was, respectively
for low- and high-MAP groups, 50% (4/8) and 38% (3/8), and in the end of the study 57% (4/7) and 0% (P = 0.026). In
septic-CG, maximal isolated skeletal muscle mitochondrial Complex I, State 3 respiration increased from 1357 ± 149
pmol/s/mg to 1822 ± 385 pmol/s/mg, (P = 0.020). In high- and low-MAP groups, permeabilized skeletal muscle fibers
Complex IV-state 3 respiration increased during resuscitation (P = 0.003).
Conclusions: The MAP targets during resuscitation did not alter the inflammatory response, nor affected skeletal
muscle ATP content and mitochondrial respiration. While targeting a lower MAP was associated with increased
incidence of AKI, targeting a higher MAP resulted in increased net positive fluid balance and vasopressor load
during resuscitation. The long-term effects of different MAP targets need to be evaluated in further studies.
Introduction
The arterial blood pressure is the driving force to blood
flow through the tissues. According to the principle of
blood flow autoregulation, if cardiac output is constant,
blood flow to tissues does not change until blood pressure
falls below a critical value. When this autoregulatory
threshold is reached, any additional decrease in arterial
blood pressure levels will compromise organ blood flow
[1].
The Surviving Sepsis Campaign Guidelines recommend
a mean arterial blood pressure (MAP) higher than 65
mmHg during the initial resuscitation of severe sepsis and
septic shock [2]. However, there is only weak evidence to
support this recommendation.
Few small prospective clinical studies have addressed
the effects of different MAP levels on tissue perfusion in
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septic shock [3-6]. Increasing MAP from 65 to 85 mmHg
has not been shown to improve systemic oxygen metabo-
lism, splanchnic perfusion or renal function, has had
inconsistent effects on local microcirculation, and has
been associated with higher left ventricular stroke work
index and increased exposure to norepinephrine [3,4,6].
Apart from influencing systemic and regional perfusion
and organ blood flow distribution [7,8], vasopressors may
also affect the balance between oxygen and substrate sup-
ply and metabolic needs [9], with the potential to affect
mitochondrial function [10], which has been associated
with organ failure and poor outcome during sepsis
[11-13]. Furthermore, in clinical practice as well as in
research, the actual blood pressure achieved is often
markedly higher than the targets originally prescribed
[14], resulting in unnecessary and potentially harmful,
further exposure to fluids and catecholamines [15].
The optimal balance between arterial blood pressure
goals and minimal side-effects of fluids and drugs needs to
be determined [16]. On one hand, aiming for higher MAP
levels during the initial resuscitation of patients in septic
shock increases the exposure to fluids, vasopressors and
inotropes, which has been associated with increased mor-
tality [15]. On the other hand, targeting lower levels of
MAP may increase the incidence of tissue hypoperfusion
and contribute to progression of organ failure [17-19].
The aim of this experimental study was to evaluate the
impact of two different levels of MAP, namely between
50 and 60 mmHg (low-MAP) or between 75 and 85
mmHg (high-MAP), on the need for resuscitation, sepsis-
associated organ dysfunction, mitochondrial respiration
and inflammatory response in a long-term model of fecal
peritonitis.
Materials and methods
This study was performed in accordance with the National
Institutes of Health guidelines for the care and use of
experimental animals and with the approval of the Animal
Care Committee of the Canton Bern, Switzerland.
Twenty-four domestic pigs of both sexes (mean weight ±
SD 41.0 ± 3.1kg) were fasted for 12 hours prior to the
experiment, with free access to water. The pigs were
sedated with intramuscular ketamine (20 mg/kg) and xyla-
zine (2 mg/kg). A peripheral intravenous catheter was
inserted in an ear vein for administration of fluids and
drugs. Pigs were orally intubated following induction
of anesthesia with midazolam (0.5 mg/kg) and atropine
(0.02 mg/kg). Anesthesia was maintained with propofol
(4 mg/kg/h) and fentanyl (5 µg/kg/h during surgery and
2 µg/kg/h afterwards). When necessary, additional injec-
tions of fentanyl (50 µg) or midazolam (5 mg) were admi-
nistered. The stomach was kept empty by insertion of a
large-bore orogastric tube.
Animals were ventilated in a volume-controlled mode
with a positive end-expiratory pressure (PEEP) of 5 cm
H2O, a fractional inspiratory oxygen concentration
(FiO2) of 30%, and a tidal volume of 8 mL/kg (Servo-i
®,
Maquet Critical Care, Solna, Sweden). The respiratory
rate was adjusted aiming an arterial carbon dioxide par-
tial pressure (PaCO2) between 35 and 45 mmHg.
Surgical preparation
The right jugular vein was cannulated via a midline cervical
incision for a pulmonary artery catheter placement. A dou-
ble lumen catheter was placed into the left femoral vein.
An arterial catheter for blood pressure measurement and
blood sampling was placed into the right carotid artery.
Ultrasound Doppler 4-mm flow probes (Transonic®
Systems Inc., Ithaca, NY, USA), which had previously been
calibrated in vitro, were placed around the left carotid
artery and the left femoral artery. With the pig in the
supine position, a midline mini-laparotomy was performed
and a large-bore intra-peritoneal drain inserted. After pre-
paration, the abdominal incision was closed. Finally,
cystostomy was performed for drainage of urine. Through-
out the surgical preparation, Ringer’s lactate was infused at
3 mL/kg/h.
Study protocol
After surgical preparation, animals were stabilized for 6 h
and Ringer’s lactate and glucose 50% (G50%) were
infused (adding up to 1.5 mL/kg/h) and adjusted to keep
blood glucose in the range of 3.5 to 5.0 mmol/L. Then,
baseline measurements were performed and pigs were
randomly assigned (n = 8 per group) to a septic control
group (septic-CG) without resuscitation until death, or to
one of two groups in which resuscitation was performed
after 12 h of untreated sepsis for 48 h, targeting MAP
between 50 and 60 mmHg (low-MAP) or between 75
and 85 mmHg (high-MAP) (Figure 1). Fecal peritonitis
was induced by peritoneal instillation of 2 g/kg body
weight of autologous feces dissolved in 250 mL warmed
glucose 5% solution. Afterwards, the intra-peritoneal
drain remained clamped throughout the experiment.
After 12 h of untreated sepsis (observation period), ani-
mals randomized to the low- and high-MAP groups were
submitted to 48 h of protocolized resuscitation (resuscita-
tion period) conducted by trained intensivists (Additional
file 1). Alternating boluses of 150 mL Ringer’s lactate and
6% hydroxyethyl starch (130/0.4) were administered when
signs of hypovolemia became evident. Fluid boluses were
repeated as long as the stroke volume was increased by
10% or more after fluid administration. The maximum
dose of hydroxyethyl starch administered during the study
was 30 mL/kg. After this maximal dose was reached, only
boluses of Ringer’s lactate were given. If the mixed venous
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oxygen saturation (SvO2) was lower than 50%, dobutamine
administration was started at a dose of 5.0 mg/h. This
dose was increased by 5.0 mg/h every 30 minutes until the
SvO2 was 50% or higher, or until a maximal dose of 20
mg/h was given. If the MAP was below 50 mmHg in the
low-MAP group and 75 mmHg in the high-MAP group,
norepinephrine was administrated (Figure S1 in Additional
file 2).
After resuscitation was started, all animals in the low-
and high-MAP groups received intravenous (i.v.) adminis-
tration of piperacillin-tazobactam (Tazobac®) 2.25 g, every
8 h, and deep vein thrombosis prophylaxis (continuous i.v.
infusion of 10,000 IU of non-fractionated heparin/24 h)
(Figure 1). Details on respiratory care and ventilator set-
tings can be found in Additional file 1. Following 48 h of
resuscitation, study animals were deeply sedated and
euthanized with an overdose of potassium chloride.
A basal fluid supply of 1.5 mL/kg/h during the observa-
tion period and 3.0 mL/kg/h during the resuscitation per-
iod was given as Ringer’s lactate and G50%, adjusted to
maintain blood glucose in the range of 3.5 to 5.0 mmol/L.
Monitoring
Hemodynamics, temperature and respiratory parameters
were monitored throughout the study, using a multi-mod-
ular patient monitor (S/5 Critical Care Monitor®; Datex-
Ohmeda, GE Healthcare, Helsinki, Finland). Thermodilu-
tion cardiac output (L/minute), mixed venous oxygen
saturation (SvO2) (Vigilance
®; Edwards Lifesciences LLC,
Irvine, CA, USA), and carotid and femoral artery blood
flows (TS 420 double-channel flowmeters, Transonic Sys-
tems Inc.) were continuously measured. Data were
recorded in software for data acquisition and signal analysis
(Soleasy™, National Instruments Corp., Austin, TX, USA),
and in an electronic patient data management system
(Centricity Clinisoft®; GE Healthcare).
Blood sampling
Techniques and time points of blood sampling for deter-
mination of blood gases, arterial lactate, electrolytes,
hemoglobin, platelets, white blood cell count, serum
creatinine, total bilirubin, creatine-kinase, troponin,
plasma IL-6 andTNF-a are described in Additional file 1.
Mitochondrial function analysis
Right quadriceps muscle samples were taken to assess iso-
lated skeletal muscle, mitochondrial function of permeabi-
lized skeletal muscle fibers, and for the quantification of
skeletal muscle, ATP content. Isolation of skeletal muscle,
liver mitochondria and mitochondrial oxygen consump-
tion (by high-resolution respirometry) were performed as
described previously [20]. An additional tissue sample was
taken from the left lobe of the liver at the end of the
experiment (Figure 1). Preparation of permeabilized mus-
cle fibers is described in detail in Additional file 1.
In septic-CG, respiration of isolated skeletal muscle mito-
chondria and permeabilized skeletal muscle fibers was
assessed at baseline, and before death occurred (end). In the
low- and high-MAP groups, isolated skeletal muscle mito-
chondria and permeabilized skeletal muscle fibers mito-
chondrial respiration were measured at baseline, end of the
observation period (EOP; before starting resuscitation) and
at the end of the experiment (END). In animals that died
earlier, the final samples were taken when the animals were
still alive and receiving the maximal norepinephrine dose
of 5,000 mcg/h, and when MAP approached 30 mmHg.
Skeletal muscle ATP content was quantified using a lucifer-
ase-based ATP determination kit (A22066, Molecular
Probes, Eugene, OR, USA).
Calculations and acute kidney injury definition
Systemic oxygen delivery (DO2; mL/min) and consump-
tion (VO2; mL/min) were calculated using cardiac output
Figure 1 Study design for the low and high mean arterial pressure (MAP) groups. Black circles, samples from the right quadriceps muscle
to assess mitochondrial function and quantification of skeletal muscle ATP content; black triangle, first dose of intravenous antibiotic
(piperacillin/tazobactam, 2.25 g, 8-hourly); black square, additional tissue samples from the liver for mitochondrial function analysis at the end of
the experiment (66 h or before death, if earlier). Animals allocated to the septic control group (Septic-CG) were followed without resuscitation
after induction of peritonitis until death. BL, baseline; PI, peritonitis induction; EOP, end of observation period (before starting resuscitation); End,
end of the experiment (at 48 hours of resuscitation or before death if earlier.
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and arterial and mixed venous blood gases, according to
standard formulas (Additional file 1). Acute kidney injury
(AKI) was defined according to the AKIN criteria as an
increase of more than 0.3 mg/dl (26.4 μmol/L) or 150% in
serum creatinine from the baseline measurement [21].
Percentage of time below or above a certain blood pres-
sure was calculated using 2-minute median-filtered values.
Statistical analysis
All data are presented as mean ± standard deviation (SD),
or median with IQR in the case of non-normal distribution
(tested by the Kolmogorov-Smirnov test). All baseline data,
fluids, vasoactive drugs, sedation, fluid balance, creatine-
kinase, troponin, liver mitochondrial respiration and skele-
tal muscle ATP content were compared between groups
using one-way analysis of variance (ANOVA) followed by
the Tukey or independent samples t-test. Binary variables
were analyzed with Fisher’s exact test and survival propor-
tions between groups were analyzed with the log rank test.
Differences between groups in the evolution over time
were assessed by ANOVA for repeated measurements
using group as the between-subject factor and time as the
within-subject factor. This was done first for all three
groups, using baseline, EOP and end values. Afterwards,
the same procedure was repeated for the low- and high-
MAP groups only, but including all measurements (base-
line, EOP, 12, 24, 36 and 48 h). If a time-group interaction
was detected between the low- and high-MAP groups, the
independent samples t-test was performed at the end of
the experiment (at 48 h of resuscitation, or before death if
earlier). In the case of non-normal distribution of study
variables, time effect was separately measured within each
group using the non-parametric Friedman’s test. At the
EOP and at the end of the experiment, all study groups
were compared with Kruskal-Wallis test, and the low- and
high-MAP groups were compared with Mann-Whitney
U-test, in the case of a significant Kruskal-Wallis test. A
potential relationship between time spent below/above dif-
ferent blood pressure levels expressed as percent, or being
administered fluids, and end plasma creatinine concentra-
tions/diuresis was evaluated using Spearman’s correlation.
The paired t-test was performed to compare baseline to
end in the septic-CG.
A P-value <0.05 was considered significant. The Statisti-
cal Package for Social Sciences (SPSS) version 20.0 (SPSS
Inc.®; Chicago, IL, USA) was used for statistical analysis.
Results
Mortality
All animals in the septic-CG died, with a median survival
time of 21.8 hs (16.3 to 27.5 h). One animal each in the
low- and high-MAP groups died during the resuscitation
period, respectively, after 38 and 19.5 h of induction of
peritonitis (Figure 2).
Treatment intensity
The high-MAP group tended to receive more fluid
boluses than the low-MAP group (P = 0.06) and had
higher cumulative fluid balance at study end (P = 0.001)
(Table 1). During the resuscitation period, norepinephr-
ine was administered to 3/8 animals (37.5%) in the low-
MAP group and to all animals in the high-MAP Group
(P = 0.026) (Table 1; see also Figure S1 in Additional
file 2). Dobutamine was administered to 4/8 animals
(50.0%) in the low-MAP and to 3/8 animals (37.5%) in
the high-MAP group (P = 1.0). Doses of administered
norepinephrine and dobutamine are shown in Table 1.
Hemodynamics, oxygen transport, respiratory and acid-
base variables
MAP at the end of the resuscitation period was 56 ± 13
mmHg and 76 ± 17 mmHg respectively, for the low- and
high-MAP groups (Table 2). During the resuscitation per-
iod, blood pressure attained overlapped to a certain extent
between the groups: in the low-MAP animals it was ≥75
mmHg during 27.5% of the time, while it was <75 mmHg
in the high-MAP group during 8.1% of the time (Table S1
in Additional file 2). None of the other hemodynamic
parameters, systemic oxygen delivery, consumption, or
arterial lactate differed between the low- and high-MAP
groups (Table 2). Arterial pH, bicarbonate, base excess,
PaCO2, minute ventilation, ratio of arterial oxygen partial
pressure to fraction of inspired oxygen and PEEP did not
differ between the low- and high-MAP groups (Table S2
in Additional file 2).
Inflammatory markers and organ function parameters
IL-6 and TNF- a plasma levels increased from baseline to
the EOP in both the low- and high-MAP groups, and
decreased during the resuscitation period (Table 3). Plate-
lets, white blood cell count, bands, metamyelocytes, total
Figure 2 Kaplan-Meyer survival curve . MAP, mean arterial
pressure; Septic-CG, septic control group.
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bilirubin, creatine-kinase and troponin did not differ
between the low- and high-MAP groups at study end
(Table 3). However, animals allocated to low-MAP exhib-
ited a higher median plasma creatinine level than animals
in the high-MAP group (P = 0.021) (Table 3; see also
Figure S2 in Additional file 2). The incidence of AKI after
12 h of untreated sepsis was, respectively for the low- and
high-MAP groups, 50% (4/8) and 38% (3/8) (P = 1.00). At
the end of the study, 57% (4/7) in the low-MAP group and
none in the high-MAP group had AKI (P = 0.026).
Mitochondrial function
Isolated skeletal muscle mitochondrial function
In the septic-CG, maximal skeletal muscle mitochondrial
respiration (complex I-state 3) increased (baseline mean ±
SD 1357 ± 149 pmol/s/mg; end 1822 ± 385 pmol/s/mg,
paired t-test: P = 0.020), whereas complex I-state 4 and
respiratory control ratio (RCR) (Figure 3a), and complex
II- and IV-dependent skeletal muscle mitochondrial
respiration did not change (Figure 3b, c). There were no
changes over time or differences between the low- and
high-MAP groups in the respiration of isolated muscle
mitochondria (Figure S3 in Additional file 2).
Isolated liver mitochondrial function
No significant differences between groups were observed
for complex I-, II- or IV-dependent respirations of isolated
liver mitochondria (Figure 4).
Permeabilized skeletal muscle fibers mitochondrial
function
Permeabilized skeletal muscle fibers complex I- and
II-dependent respiration did not change in the low-
and high-MAP groups (Table S3 in Additional file 2).
However, complex IV-state 3 respiration increased in the
low- and high-MAP groups during the resuscitation per-
iod (P = 0.003 for time effect) with no difference between
the groups (Table S3 in Additional file 2). Permeabilized
skeletal muscle fibers respiration did not change in the
septic-CG (Table S4 in Additional file 2).
Skeletal muscle ATP content
Skeletal muscle ATP content was preserved in all groups
(Figure 5).
Discussion
Blood pressure targets did not modify mitochondrial
respiration or markers of inflammation. However, animals
in the low-MAP group had lower SvO2 and hemoglobin
levels, and a higher incidence of AKI, while animals in the
high-MAP group had increased net positive fluid balance
and vasopressor load during resuscitation. If the animals
were not resuscitated after 12 h they died, with increased
plasma levels of inflammatory markers, increased maximal
skeletal muscle complex I mitochondrial respiration, and
with preserved skeletal muscle ATP content.
Few clinical studies have prospectively addressed the
effect on disease severity and the development of sepsis-
associated organ dysfunction of different levels of MAP
during the initial phase of severe sepsis and septic shock
resuscitation [3-6]. The lack of available data supporting a
specific MAP target during the initial resuscitation of
septic patients is emphasized by the wide range of MAP
goals (60 to 100 mmHg) applied in randomized controlled
clinical trials [16]. Furthermore, experimental studies in
sepsis either do not include MAP targets in resuscitation
algorithms [22-24], or set the MAP target at 65 mmHg
[25,26], consistent with the current recommendation of
the Surviving Sepsis Campaign [2]. Nevertheless, no clini-
cal or experimental studies have prospectively addressed
Table 1 Administered treatment, fluid output and









Propofol, mg/kg/h 5.0 ± 1.0 5.8 ± 0.7 5.8 ± 0.5 0.11a
Fentanyl, mcg/kg/h† 4.0 ± 1.6 3.9 ± 0.8 4.4 ± 0.9 0.62a








Median 0.7 2.0 0.06b







Median dose, mcg/kg/min 0.00 0.38 0.009b




4/8 (50.0) 3/8 (37.5) 1.00c
Median dose, mcg/kg/min 0.06 0.00 0.45b
IQR 0.00, 3.16 0.00, 1.00
Total volume received, mL/
kg/h
1.5 ± 0.0 3.6 ± 0.8§ 4.7 ± 1.4# 0.001a
Urine output, mL/kg/h 0.6 ± 0.1 1.0 ± 0.2§ 1.1 ± 0.2# 0.001a
Gastric tube output, mL/kg/
h
0.3 ± 0.2 0.3 ± 0.3 0.3 ± 0.2 0.95a
Final balance╫, mL/kg/h 0.6 ± 0.3 2.3 ± 0.7§ 3.3 ± 1.0#
¥
0.001a
Final balance╫, L 0.5 ± 0.4 5.2 ± 1.1§ 6.7 ± 1.4#
¥
0.001a
Values are mean ± SD or median (IQR) unless stated otherwise. †Sum of basic
fentanyl infusion with additional boluses; *administered during the 48-h
resuscitation period; ††sum of Ringer’s lactate and hydroxyethyl starch; ╫final
balance = (Ringer’s Lactate basal infusion + glucose 50% basal infusion + Ringer’s
lactate bolus + hydroxyethyl starch bolus) - (urine output + gastric tube output);
aone-way analysis of variance (ANOVA). Tukey post hoc test after ANOVA,
comparisons significant at the 0.05 level: ¥low-mean arterial pressure (MAP)
versus high-MAP; §low-MAP versus septic control group (Septic-CG); #high-MAP
versus Septic-CG; bMann-Whitney test; cFisher’s exact test.
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the effects of lower MAP targets (50 to 60 mmHg) on
outcomes.
Jhanji et al. have shown that in a case series of sixteen
patients with septic shock, increasing MAP from 60 to 90
mmHg using norepinephrine improved systemic oxygen
delivery and cutaneous PtO2, did not affect sublingual
microvascular flow and did not improve urinary output
[5]. In our study, systemic oxygen delivery increased simi-
larly in the low- and high-MAP groups, and systemic oxy-
gen consumption was maintained in all groups. However,
four out of seven animals (57%) allocated to the low-MAP
group, in comparison to none in the high-MAP group,
presented with AKI at the end of study. In an experimen-
tal sepsis model using either endotoxemia or fecal peri-
tonitis for 22 h with MAP >70 mmHg, Benes et al.
demonstrated a similar overall incidence of AKI of 50%
[27]. It has been postulated that higher MAP levels
(approximately 70 to 80 mmHg) may be necessary to
decrease the development of AKI in patients with septic
shock [17]. In our study, animals allocated to attainment
Table 2 Systemic and regional hemodynamics and arterial lactate level
Variable Group BL EOP RP 12 h RP 24 h RP 36 h RP 48h END P-value¶
MAP, Septic-CG 78 ± 9 68 ± 22 29 ± 4 <0.001a
mm Hg Low-MAP 65 ± 9 81 ± 16 72 ± 13 67 ± 12 61 ± 6 59 ± 8 56 ± 13 <0.001a
High-MAP 63 ± 7 76 ± 11 86 ± 5 81 ± 7 82 ± 4 82 ± 3 76 ± 17
Heart rate, Septic-CG 104 ± 17 193 ± 41 216 ± 25 <0.001a
beats/minute Low-MAP 93 ± 11 166 ± 23 165 ± 14 156 ± 23 141 ± 28 122 ± 28 130 ± 46 0.84b
High-MAP 105 ± 23 173 ± 31 163 ± 22 155 ± 31 138 ± 28 117 ± 29 117 ± 29
MPAP, Septic-CG 12 ± 2 16 ± 3 11 ± 2 <0.001a
mm Hg Low-MAP 15 ± 3 18± 2 20 ± 5 21 ± 5 23 ± 6 23 ± 5 23 ± 4 0.19b
High-MAP 13 ± 1 18 ± 3 19± 2 21 ± 1 24 ± 2 24 ± 3 27 ± 9
CVP, Septic-CG 1 ± 1 1 ± 1 0 ± 1 <0.001a
mm Hg Low-MAP 4 ± 2 2 ± 2 3 ± 2 5 ± 3 7 ± 4 8 ± 4 9 ± 4 0.41b
High-MAP 2 ± 1 1 ± 1 3 ± 2 6 ± 1 7 ± 1 9 ± 2 10 ± 3
SVRI, Septic-CG 692 ± 129 966 ± 197 600 ± 238 0.082a
mm Hg Low-MAP 589 ± 60 923 ± 203 668 ± 131 451 ± 131 373 ± 56 349 ± 92 319 ± 119 0.19b
L/Kg/min High-MAP 553 ± 87 1017 ± 304 698 ± 114 525 ± 185 488 ± 109 510 ± 107 475 ± 140
Cardiac Septic-CG 115 ± 27 70 ± 21 53 ± 19 <0.001a
index, Low-MAP 105 ± 13 88 ± 22 104 ± 13 143 ± 31 145 ± 13 149 ± 19 150 ± 18 0.38b
mL/kg/min High-MAP 112 ± 23 77 ± 16 122 ± 29 165 ± 78 160 ± 36 150 ± 31 142 ± 35
SvO2, Septic-CG 59 ± 8 53 ± 12 35 ± 11 0.001
a
% Low-MAP 48 ± 2 56 ± 9 58 ± 9 56 ± 9 60 ± 6 61 ± 7 55 ± 17 0.06b
High-MAP 50 ± 8 51 ± 3 61 ± 6 66 ± 3 66 ± 5 67 ± 5 60 ± 20
DO2, Septic-CG 626 ± 163 592 ± 158 421 ± 113 <0.001
a
mL/min Low-MAP 526 ± 118 663 ± 172 682 ± 100 748 ± 99 712 ± 93 687 ± 149 687 ± 149 0.26b
High-MAP 541 ± 92 566 ± 78 749 ± 118 919 ± 444 862 ± 201 744 ± 135 702 ± 173
VO2, Septic-CG 241 ± 27 267 ± 44 280 ± 91 0.293
a
mL/min Low-MAP 277 ± 46 284 ± 38 281 ± 28 298 ± 27 282 ± 35 254 ± 39 254 ± 39 0.95b
High-MAP 269 ± 50 273 ± 44 280 ± 49 306 ± 120 276 ± 34 247 ± 30 256 ± 38
CBFI, Septic-CG 6.7 ± 1.3 3.9 ± 0.5 2.8 ± 0.6 <0.001a
mL/kg/min Low-MAP 6.9 ± 2.2 4.9 ± 2.1 6.4 ± 1.9 8.5 ± 2.1 8.4 ± 1.6 8.0 ± 1.6 7.6 ± 1.8 0.55b
High-MAP 5.4 ± 1.6 4.1 ± 1.2 5.6 ± 1.6 6.7 ± 1.6 6.8 ± 1.8 6.2 ± 1.8 5.8 ± 2.0
FBFI, Septic-CG 3.5 ± 0.7 1.7 ± 0.5 1.2 ± 0.3 <0.001a
mL/kg/min Low-MAP 3.9 ± 1.6 1.7 ± 0.8 2.2 ± 0.4 3.4 ± 1.0 3.8 ± 0.6 3.9 ± 0.9 3.7 ± 1.0 0.33b
High-MAP 3.1 ± 0.9 1.4 ± 0.6 2.2 ± 0.7 3.2 ± 1.0 3.2 ± 0.8 3.4 ± 0.7 3.1 ± 1.0
Arterial Septic-CG 0.7 ± 0.1 1.9 ± 1.2 4.1 ± 2.0 <0.001a
lactate, Low-MAP 1.3 ± 0.6 1.0 ± 0.4 1.2 ± 0.3 1.1 ± 0.4 1.1 ± 0.5 0.9 ± 0.2 1.0 ± 0.4 0.19b
mmol/L High-MAP 0.9 ± 0.3 1.0 ± 0.2 1.2 ± 0.5 1.2 ± 0.5 1.1 ± 0.2 1.1 ± 0.3 1.5 ± 1.4
Values are mean ± SD. BL, baseline; EOP, end of observation period for the low-MAP and high-MAP groups (12 h after induction of peritonitis); RP, resuscitation period;
END, end of the experiment (at 48 hours of resuscitation, or before death if earlier); MAP, mean arterial blood pressure; MPAP, mean pulmonary artery pressure; PAOP,
pulmonary artery occlusion pressure; CVP, central venous pressure; SVRI, systemic vascular resistance index; SvO2, mixed venous oxygen saturation; DO2, systemic
oxygen delivery; VO2, systemic oxygen consumption; CBFI, carotid artery flow index; FBFI, femoral artery flow index;
¶P-value for atime-group interaction with repeated
measures analysis of variance (ANOVA) including BL, EOP and END for all study groups (septic control (Septic-CG), Low-MAP and High-MAP groups); btime-group
interaction with repeated measures ANOVA including BL, EOP, RP 12 h, RP 24 h, RP 36 h and RP 48 h for the Low-MAP and High-MAP groups.
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of MAP between 75 to 85 mmHg received higher amounts
of both fluids and norepinephrine in comparison to ani-
mals allocated to the low-MAP group. We found a signifi-
cant correlation between percentage of time spent with
blood pressure >60 mmHg and plasma creatinine in the
end of the study, but not between the amount of adminis-
tered fluids and plasma creatinine. It seems unlikely there-
fore, that more fluid per se would have been beneficial in
the low-MAP group.
Data from experimental [24,28] and clinical studies
[15,29-37] have shown that therapeutic attempts, includ-
ing administration of fluids and vasopressors to restore
hemodynamic stability during sepsis may be associated
with poor outcomes. In critically ill septic and non-septic
patients, the cumulative positive fluid balance has been
associated with a worse outcome [29-31,34,36,37], and the
administration of catecholamines, particularly at higher
doses, was associated with derangements in regional blood
Table 3 Inflammatory markers and organ function analysis
Variable Group BL EOP End P-value¶
IL-6, Septic-CG 24 ± 44 781 ± 410* 1785 ± 819 <0.001a
pg/mL Low-MAP 20 ± 26 291 ± 165 57 ± 59# 0.61b
High-MAP 5 ± 10 258 ± 107 95 ± 177
TNF-a, Septic-CG 102 ± 75 290 ± 145* 410 ± 160 <0.001a
pg/mL Low-MAP 48 ± 16 149 ± 55 93 ± 45# 0.52b
High-MAP 57 ± 39 130 ± 89 76 ± 65
Hemoglobin, Septic-CG 9.4 ± 0.8 15.4 ± 1.6 14.7 ± 1.8 <0.001a
mg/dL Low-MAP 9.3 ± 0.6 14.7 ± 0.7 8.4 ± 0.8 0.014b
High-MAP 9.2 ± 0.4 14.8 ± 1.2 10.0 ± 1.2 0.008c
Platelets, Septic-CG 296 ± 97 131 ± 66* 98 ± 53 0.18a
x 109/L Low-MAP 255 ± 48 176 ± 41 115 ± 42# 0.19b
High-MAP 323 ± 102 131 ± 66 98 ± 53
White blood cell count, Septic-CG 14.0 ± 1.6 9.7 ± 3.0* 10.7 ± 2.8 0.013a
x 109/L Low-MAP 18.4 ± 5.2 12.6 ± 4.1 16.9 ± 5.2# 0.014b
High-MAP 16.9 ± 3.5 18.2 ± 5.0 18.9 ± 4.7 0.46c
Bands, Septic-CG 2.8 ± 4.1 38.1 ± 8.2* 28.6 ± 19.8 0.021a
% Low-MAP 11.6 ± 15.6 57.2 ± 9.6 23.4 ± 18.2# 0.05b
High-MAP 0.8 ± 0.7 63.9 ± 8.6 27.4 ± 10.0 0.59c
Metamyelocytes, Septic-CG 0.0 ± 0.0 14.3 ± 12.1* 12.5 ± 7.5 0.001a
% Low-MAP 0.0 ± 0.0 6.2 ± 3.3 1.9 ± 3.6# 0.93b
High-MAP 0.0 ± 0.0 6.5 ± 4.1 1.4 ± 3.0
Creatinine, Septic-CG 0.5 (0.4, 0.8) 1.6 (1.4, 1.6)* 2.3 (2.0, 2.6) <0.03d
mg/dl, median (IQR) Low-MAP 0.9 (0.8, 1.0) 1.2 (1.0, 1.7) 1.4 (1.0, 2.1)# 0.295e
High-MAP 0.9 (0.8, 0.9) 1.1 (0.9, 1.2) 0.9 (0.7, 1.0) 0.001f
0.021g
Total bilirubin, Septic-CG 1.6 ± 1.2 1.0 ± 0.0* 1.1 ± 0.4 >0.60d
µmol/L Low-MAP 1.5 ± 1.1 1.4 ± 1.1 1.6 ± 1.5#
High-MAP 1.3 ± 0.5 1.1 ± 0.4 1.4 ± 0.7
Creatine-kinase, Septic-CG 475 (360, 779) 0.045f
U/L, median (IQR) Low-MAP 253 (232, 470) 0.28g
High-MAP 211 (183, 332)
Troponin, Septic-CG 0.015 (0.013, 0.032) 0.091f
µg/L, median (IQR) Low-MAP 0.008 (0.05, 0.028)a#
High-MAP 0.007 (0.006, 0.02)
Values are mean ± SD or median (IQR) where indicated. BL, baseline; EOP, end of observation period for Low-mean arterial pressure (MAP) and High-MAP
groups (12 h after induction of peritonitis); END, end of the experiment (at 48 hours of resuscitation, or before death if earlier); #data available for seven animals;
*data available for five animals, in one measured after 24 h of PI, and in four after 18 h of PI; ¶P-value for atime-group interaction with repeated measures
analysis of variance (ANOVA) including BL, EOP and END for all study groups (septic control (Septic-CG), Low-MAP and High-MAP groups); btime-group
interaction with repeated measures ANOVA including BL, EOP and END for Low-MAP and High-MAP groups; cindependent samples t-test between Low-MAP and
High-MAP groups at the END; dtime effect within each group (Septic-CG, Low-MAP and High-MAP) separately assessed by the non-parametric Friedman’s test
and including BL, EOP and END; eKruskal-Wallis test at the EOP; fKruskal-Wallis test at the End; gMann-Whitney U-test between Low-MAP and High-MAP groups
at the END.
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flow [7,8], adverse side effects [33,35] and increased likeli-
hood of death [15,32,35]. In our experimental model such
effects were not observed or observable. However, whether
renal hyperfiltration as a result of high blood pressure and
volume load may cause delayed harm to septic kidneys
should be addressed in further studies.
Sepsis may result in various changes in mitochondrial
enzyme activity and tissue ATP. Muscle complex-I
activity decreased and complex-IV activity have been
found to be increased in patients who subsequently died
in sepsis [13], whereas an acute endotoxin challenge is
reported to increase muscle complex-I activity in
healthy volunteers [38]. Reduced tissue ATP levels have
been observed in various tissues and sepsis models, but
not consistently. Quadriceps muscle ATP was found to
be reduced in non-survivors of sepsis but not in survi-
vors [13]. In severe sepsis, intercostal muscle ATP is
reported as normal, while leg muscle ATP is decreased
[39]. In experimental sepsis decreased ATP content has
been reported in the rat liver and the kidney but not in
the muscle [40,41], and in the liver in porcine bacterial
sepsis [42]. In porcine endotoxemia, reduced ATP con-
tent in the intestinal mucosa but not muscularis [43], as
well as unchanged intestinal wall ATP has been reported
[44].
Instead of respiratory chain enzyme activities, we
assessed mitochondrial respiration using substrate-induced
maximal oxygen consumption. We found no signs of
impaired mitochondrial respiration in the muscle-isolated
mitochondria or in the permeabilized muscle fibers, and
the muscle ATP levels remained unchanged, even in the
untreated septic group, with 100 % mortality. In contrast,
complex I-dependent state 3 respiration of isolated muscle
mitochondria increased in untreated sepsis, and complex
IV-dependent state 3 respiration increased in the permea-
bilized muscle fibers in the resuscitated septic groups.
Figure 3 Isolated skeletal muscle mitochondrial respiration during unresuscitated sepsis. Complex I-, II- and IV-isolated skeletal muscle
mitochondrial respiration in septic control animals from baseline to end (represented by connecting lines for each pig, n = 8). State 3 and State 4
oxygen consumption is expressed as pmol/second/mg protein. State 3, active respiration after addition of ADP; State 4, respiration after consumption
of ADP. The ratio between State 3 and State 4 was calculated as the respiratory control ratio (RCR; state 3/state 4). *P = 0.02, paired t-test.
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In the presence of unchanged RCR and muscle ATP con-
tent, this may be related to increased metabolic activity
and increased ADP transport into mitochondria [45]. One
mechanism which may help to maintain ATP levels in sep-
sis is increased phosphocreatine breakdown, which pro-
vides fuel for various cellular processes [41].
We observed previously that delay in starting resusci-
tation was associated with decreased muscle ATP levels
at the time of death [28], in contrast to the well-pre-
served muscle ATP levels in the present study. Deaths
in that study occurred later, after a period of resuscita-
tion, whereas in the present study the deaths occurred
earlier, and all except two resuscitated animals survived.
The well-preserved muscle ATP levels in the dying ani-
mals in the present study are likely to be related to the
earlier death.
Resuscitation to a low compared to a high MAP target
had no effect on isolated skeletal muscle mitochondrial
respiration, or on isolated liver mitochondrial respiration,
suggesting that neither higher organ perfusion pressure
nor increased vasopressor load had an effect. We pre-
viously observed that the need to support hemodynamics
with norepinephrine in porcine fecal peritonitis of shorter
duration was associated with lower hepatic complex II-
dependent state 4 respiration, while state 3 and RCR were
not altered [20]. We also found in endotoxemic pigs that
norepinephrine improved hepatic mitochondrial respira-
tory efficiency [46]. Similarly, norepinephrine tended to
increase ileal wall mitochondrial complex-I activity in an
endotoxemic sheep model [47]. The lack of difference in
the liver mitochondrial respiration between the groups in
the present study suggests that the effect of norepinephrine
Figure 4 Isolated liver mitochondrial respiration. Comparison of isolated liver mitochondrial respiration in septic control animals and septic
animals resuscitated to low-mean arterial pressure (MAP) and high-MAP targets (n = 8). State 3 and 4 oxygen consumption is expressed as
pmol/second/mg protein. No significant differences were found between the groups (P >0.05, one-way analysis of variance). Horizontal lines
represent mean values. Filled circles represent animals that died early. State 3, active respiration after addition of ADP; State 4, respiration after
consumption of ADP; RCR, respiratory control ratio (oxygen consumption of State 3/State 4).
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on the liver is model-dependent or related to the duration
of exposure.
Our study has limitations. We evaluated only two ranges
of MAP for the initial resuscitation of severe sepsis and
septic shock. Second, respiration rates were not normal-
ized to the citrate synthase activity (mitochondrial con-
tent) [48]. Reduced skeletal muscle mitochondrial enzyme
activity has been observed in patients with sepsis and mul-
tiple organ failure if expressed per wet muscle weight, but
not if normalized to citrate synthase activity, a marker of
mitochondrial content [39]. This may suggest decreased
mitochondrial mass rather than specific inhibition of the
mitochondrial enzymes in sepsis. Consequently, our find-
ing of increased permeabilized muscle fibers complex
IV-respiration may be due to variations in mitochondrial
content. Third, the final skeletal muscle and liver samples
in the animals that died before completing the 48-hour
resuscitation period were taken when MAP approached
30 mmHg, and therefore may potentially reflect a near-
death state rather than non-confounded differences
between the study groups. Fourth, we did not evaluate the
microcirculation in animals resuscitated with a low MAP
target. It is possible that lower MAP is associated with
decreased microvascular blood flow [49]. Fifth, we studied
a small number of animals per group. Therefore, there is a
risk of a type II error, and we cannot exclude true, small,
undetected differences between groups. Finally, in this
model of fecal peritonitis in young, healthy pigs, MAP
thresholds may not have the same importance for tissue
oxygenation as in older septic patients.
Conclusions
In this abdominal sepsis model with 100% mortality
unless treatment is installed, the MAP targets of 50 to
60 mmHg versus 75 to 85 mmHg during resuscitation
did not result in differences in the inflammatory
response skeletal muscle ATP content, or in mitochon-
drial respiration. While targeting a lower MAP was asso-
ciated with increased incidence of AKI, targeting a
higher MAP resulted in increased net positive fluid bal-
ance and vasopressor load during resuscitation. The
long-term effects on kidney function of using lower
MAP targets, and whether the resulting increased fluid
balance and vasopressor load using higher MAP targets
are of relevance for recovery after initial resuscitation,
need to be evaluated in further studies.
Key messages
• Targeting a MAP between 50 and 60 mmHg in septic
shock was associated with increased incidence of AKI.
• Targeting a higher MAP (75 to 85 mmHg) during
resuscitation did not ameliorate the inflammatory
response and resulted in increased net positive fluid bal-
ance and vasopressor load during resuscitation.
• MAP targets did not modify the inflammatory
response, the skeletal muscle ATP content or mitochon-
drial respiration.
• Unresuscitated septic animals died, with increased
plasma levels of inflammatory markers, increased maxi-
mal skeletal muscle complex-I mitochondrial respiration,
and with preserved skeletal muscle ATP content.
Figure 5 Skeletal muscle tissue ATP concentrations in septic controls and animals resuscitated to low-mean arterial pressure (MAP)
and high-MAP targets. The black horizontal bars represent the mean values. Filled circles represent animals that died early. P >0.05 for all
comparisons. BL, baseline; EOP, end of observation period; END, end of the experiment (at 48 h of resuscitation, or before death if earlier).
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Additional material
Additional file 1: Word text file containing additional information
about the methods, along with related references.
Additional file 2: Word file containing four tables and three figures.
Table S1 indicates the percentage of time spent at different blood
pressure ranges. Table S2 describes the acid-base-balance parameters
and respiratory system variables. Table S3 gives permeabilized skeletal
muscle fibers maximal mitochondrial respiration (state 3) in animals
resuscitated to low and high-mean arterial pressure (MAP) targets. Table
S4 lists permeabilized skeletal muscle fibers maximal mitochondrial
respiration (state 3) in the septic control group. Figure S1 shows the
MAP and norepinephrine administration over the study period in animals
randomized to the low and high-MAP groups. Figure S2 shows a scatter
plot of plasma creatinine in the three study groups. Figure S3 shows
isolated skeletal muscle mitochondrial respiration in animals resuscitated
to low and high MAP.
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